The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma.
- DOI
- 10.1007/s10238-026-02267-4
- Published
- 2026 Jul 31
- Container
- Clinical and experimental medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10238-026-02267-4,
title = {The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma.},
author = {Qiu J and Cao L and Li Y and Li Y and Yin Z and Kong D and Chen N and Wang Z},
year = {2026},
journal = {Clinical and experimental medicine},
doi = {10.1007/s10238-026-02267-4},
url = {https://doi.org/10.1007/s10238-026-02267-4}
}RIS
TY - JOUR TI - The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma. AU - Qiu J AU - Cao L AU - Li Y AU - Li Y AU - Yin Z AU - Kong D AU - Chen N AU - Wang Z PY - 2026 JO - Clinical and experimental medicine DO - 10.1007/s10238-026-02267-4 UR - https://doi.org/10.1007/s10238-026-02267-4 ER -
APA
J, Q., L, C., Y, L., Y, L., Z, Y., D, K., N, C., & Z, W. (2026). The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma.. Clinical and experimental medicine. https://doi.org/10.1007/s10238-026-02267-4
Source records
- pubmed · retrieved 2026-09-25T21:40:50.450Z